Metabolic control at two months to 4.5 years after pancreatic transplantation, with special reference to the role of cyclosporine.
Tydén
G
G
Department of Transplantation Surgery, Karolinska Institute, Huddinge Hospital, Stockholm, Sweden.
Brattström
C
C
Gunnarsson
R
R
Lundgren
G
G
Ost
L
L
Ostman
J
J
Groth
C G
CG
D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D001786:Blood Glucose / Q000378:metabolism; D003524:Cyclosporins / Q000627:therapeutic use*; D003922:Diabetes Mellitus, Type 1 / Q000601:surgery; D003928:Diabetic Nephropathies / Q000601:surgery; D005500:Follow-Up Studies; D005951:Glucose Tolerance Test; D006442:Glycated Hemoglobin / Q000032:analysis; D006085:Graft Survival; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D016035:Pancreas Transplantation / Q000276:immunology / Q000379:methods / Q000502:physiology*; D011239:Prednisolone / Q000627:therapeutic use
D000961:Antilymphocyte Serum; D001379:Azathioprine; D001786:Blood Glucose; D003524:Cyclosporins; D006442:Glycated Hemoglobin; D011239:Prednisolone